HIV and AIDS Trial, Recruiting NCT05807867 Sponsor: New York University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05807867
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has three different groups of participants. Each group has its own set of criteria.

Group A: Women with a serious mental illness (SMI) and HIV

  • People who have been diagnosed with a current psychotic disorder, mood disorder, or another condition causing difficulties with daily life (not including substance use disorders or developmental disorders), as confirmed by a clinician interview
  • People who have a confirmed HIV-positive diagnosis
  • People who are between 18 and 55 years of age
  • People who are female
  • People who are able to understand and agree to participate, and can sign a consent form
  • People who speak English or Setswana
  • People who are citizens of Botswana

For women being considered as peer co-leaders within this group, the above criteria apply, plus:

  • People who have been consistently taking their psychiatric medications
  • People whose mental health symptoms have been stable for more than 2 years
  • People who have been consistently following their HIV treatment (ART) plan

Group B: Family members of women with SMI and HIV

  • People who have been identified by the participant and/or their clinician as the family member most involved in the participant's care
  • People who are between 18 and 65 years of age
  • People who speak English or Setswana
  • People who are citizens of Botswana

Group C: Policy makers and other stakeholders

  • People who are between 18 and 55 years of age
  • People who are senior government officials in Botswana's public sector ministries involved in developing, interpreting, or carrying out national mental health and HIV programs or related services; OR senior officials of the National AIDS and Health Promotion Agency (NAHPA); OR senior members of civil society organisations, non-government organisations, or similar bodies that support the Botswana government in delivering services to people living with HIV or mental health conditions

Who may not be able to join:

  • People whose mental health diagnosis falls under substance use disorders or developmental disorders (Group A only)
  • People who do not speak English or Setswana (all groups)
  • People who are not citizens of Botswana (all groups)
  • People outside the specified age ranges for each group
  • People who are not female (Group A only)
  • People who do not have the ability to understand and give informed consent (Group A only)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lawrence Yang, PhD, New York University

Phone: 267 355 4855

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
New York University
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 December 2027

Where this trial is recruiting

Botswana

Primary endpoints

Viral load (VL); Viral load

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov